SRPTSarepta Therapeutics, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $22.83 (+0.35% today)

Market Cap: $2.39B

P/E (TTM): -3.30

Forward P/E (FY1): 7.60

EPS Growth: -61.1%

Analyst Upside: 18.3%

Relative Strength (RS%): 68

-64.8% from 52-week high

Back to Scanner

SRPT

NASDAQRS 68Score 45

Sarepta Therapeutics, Inc.

HealthcareBiotechnology$2.39B2 setups passing
$22.83
+0.4% ($0.08)
-64.8% from 52W High
P/E (TTM)
-3.30
Fwd P/E
7.60
PEG
0.05
Analyst Upside
+18.3%
EPS Growth
-61.1%
Gross Margin
61.8%
ROE
-57.5%
D/E
0.91
Div Yield
0.0%
Avg Volume
2.3M

Price Chart

Key Levels

SMA 200
$19.43
SMA 50
$18.83
Price
$22.83
52W High
$64.86
Target
$27.00

Setup Radar

2/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst